首页> 外文期刊>Journal of Comparative Pathology >A Comprehensive Test System to Identify Suitable Antibodies Against p53 for Immunohistochemical Analysis of Canine Tissues
【24h】

A Comprehensive Test System to Identify Suitable Antibodies Against p53 for Immunohistochemical Analysis of Canine Tissues

机译:一种综合测试系统,用于鉴定针对P53的合适抗体进行犬组织的免疫组化分析

获取原文
获取原文并翻译 | 示例
           

摘要

The tumour suppressor p53 is commonly detected in tissues of companion animals by means of antibodies raised against the human protein. The following three-step procedure was devised to test the suitability of such antibodies for immunohistochemistry on canine tissues. (1) Western blot and immunohistochemical analyses on bacterially expressed recombinant canine protein to assess human-to-canine cross-reactivity. (2) Immunohistochemistry of cultured, UVB-irradiated canine keratinocytes to evaluate suitability for detection of endogenous p53. (3) Immunohistochemistry on tissue arrays to further substantiate suitability of the antibodies on a panel of normal and neoplastic human and canine tissues. Five of six antibodies cross-reacted with recombinant canine p53. Three of these (PAb122, PAb240, CM-1) also immunolabelled stabilized wild type p53 in cell cultures and elicited a consistent, characteristic labelling pattern in a subset of tumours. However, two alternative batches of polyclonal antibody CM-1 failed to detect p53 in cell cultures, while showing a characteristic labelling pattern of a completely different subset of tumours and unspecific labelling of normal tissues. The test system described is well suited to the selection of antibodies for immunohistochemical p53 detection. The results emphasize the need to include appropriate controls, especially for polyclonal antibodies.
机译:肿瘤抑制剂P53通常通过针对人蛋白施加的抗体在伴侣动物的组织中检测到。设计了以下三步程序,以测试这种抗体对犬类组织免疫组织化学的适用性。 (1)对细胞表达的重组犬蛋白蛋白的免疫印迹和免疫组织化学分析评估人对犬的交叉反应性。 (2)培养的免疫组化,UVB辐照犬角蛋白细胞,评价用于检测内源P53的适用性。 (3)组织阵列免疫组织化学,以进一步证实抗体对正常和肿瘤人和犬组织面板上的适用性。六种抗体中的五种与重组犬P53交叉反应。其中三种(PAB122,PAB240,CM-1)也免疫标签稳定的野生型P53在细胞培养物中,并在肿瘤的子集中引发了一致的特征标记图案。然而,两种替代批次的多克隆抗体CM-1未能检测细胞培养物中的p53,同时显示完全不同肿瘤子集的特征标记图案和正常组织的未指定标记。所描述的测试系统非常适合于选择免疫组织化学P53检测的抗体。结果强调需要包括适当的对照,特别是对于多克隆抗体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号